RARE Grant Program (Research Accelerating RUNX1 Exploration)
Forecasted
The RARE Grant Program funds research on preventing or intercepting cancer progression in RUNX1-FPD, focusing on childhood cancer, from Alex's Lemonade Stand Foundation.
Funder: Alex's Lemonade Stand Foundation
Due Dates (Anticipated): December 2026 (application deadline, projected)
Funding Amounts: $250,000 total over 2 years (up to $125,000/year)
Summary: Supports innovative research to prevent or intercept cancer progression in patients with RUNX1-FPD, with a focus on childhood cancer.
Key Information: This is a forecasted opportunity; dates are projected and may shift.
Description
The RARE Grant Program (Research Accelerating RUNX1 Exploration), funded by Alex's Lemonade Stand Foundation, is dedicated to advancing research on RUNX1 familial platelet disorder (RUNX1-FPD). The program supports projects aimed at understanding and treating RUNX1-FPD, specifically focusing on developing therapies that can intercept the transition from a precancerous state (clonal hematopoiesis) to myelodysplastic syndrome or acute myeloid leukemia (MDS/AML), or prevent cancer before clonal hematopoiesis occurs. The ultimate goal is to enable new clinical breakthroughs in childhood cancer by fostering innovative, translational research with the potential for high impact.
